Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$7.30
-1.7%
$7.81
$6.72
$16.16
$229.88M1.31266,817 shs58,143 shs
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$137.52
-4.0%
$149.15
$66.03
$161.00
$8.01B0.5365,360 shs139,092 shs
CLZ
Canasil Resources
C$0.03
C$0.03
C$0.01
C$0.05
C$4.31M1.7696,884 shs44,800 shs
CNX Resources Co. stock logo
CNX
CNX Resources
$23.99
-0.9%
$22.43
$14.36
$24.82
$3.67B1.332.95 million shs2.78 million shs
NVV
Norvista Capital
C$0.08
-6.3%
C$0.08
C$0.07
C$0.23
C$5.26MN/A116,000 shs112,500 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Aaron's Company, Inc. stock logo
AAN
Aaron's
+1.22%+4.86%+1.64%-30.63%-41.05%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-1.14%+0.71%-0.89%+8.68%+82.72%
CLZ
Canasil Resources
0.00%0.00%0.00%0.00%+20.00%
CNX Resources Co. stock logo
CNX
CNX Resources
+0.56%+1.49%+4.92%+18.59%+57.69%
NVV
Norvista Capital
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Aaron's Company, Inc. stock logo
AAN
Aaron's
4.0156 of 5 stars
3.23.04.20.00.61.73.1
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
1.3661 of 5 stars
3.41.00.00.01.81.70.6
CLZ
Canasil Resources
N/AN/AN/AN/AN/AN/AN/AN/A
CNX Resources Co. stock logo
CNX
CNX Resources
3.3587 of 5 stars
2.01.00.00.02.42.53.8
NVV
Norvista Capital
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Aaron's Company, Inc. stock logo
AAN
Aaron's
2.33
Hold$11.6759.82% Upside
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
2.88
Moderate Buy$173.2525.98% Upside
CLZ
Canasil Resources
N/AN/AN/AN/A
CNX Resources Co. stock logo
CNX
CNX Resources
2.00
Hold$24.431.83% Upside
NVV
Norvista Capital
N/AN/AN/AN/A

Current Analyst Ratings

Latest AAN, CNX, ASND, NVV, and CLZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$116.00 ➝ $116.00
4/19/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$18.00 ➝ $22.00
4/18/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
4/11/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Underperform ➝ Sector Underperform$20.00 ➝ $25.00
4/11/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $25.00
4/5/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$28.00 ➝ $30.00
4/2/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $167.00
4/2/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$18.00 ➝ $22.00
4/1/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$173.00
3/15/2024
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$196.00 ➝ $260.00
3/13/2024
CNX Resources Co. stock logo
CNX
CNX Resources
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$27.00 ➝ $28.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$2.14B0.11$18.72 per share0.39$22.62 per share0.32
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$288.08M27.79N/AN/A($2.73) per share-50.37
CLZ
Canasil Resources
N/AN/AC$0.00 per share40.00N/AN/A
CNX Resources Co. stock logo
CNX
CNX Resources
$3.47B1.06$5.03 per share4.77$27.45 per share0.87
NVV
Norvista Capital
C$-1.27M-4.13C$0.12 per share0.63C$0.11 per share0.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$2.82M$0.0891.2510.90N/A0.13%3.59%1.38%5/6/2024 (Confirmed)
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$521.07M-$9.25N/AN/AN/A-180.61%-16,574.15%-55.10%4/25/2024 (Estimated)
CLZ
Canasil Resources
-C$1.23M-C$0.01N/AN/AN/A-990.66%-292.03%N/A
CNX Resources Co. stock logo
CNX
CNX Resources
$1.72B$9.092.6412.83N/A50.34%9.00%4.20%4/25/2024 (Confirmed)
NVV
Norvista Capital
N/A-C$0.05N/AN/AN/AN/AN/AN/A

Latest AAN, CNX, ASND, NVV, and CLZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
The Aaron's Company, Inc. stock logo
AAN
Aaron's
-$0.08N/A+$0.08N/AN/AN/A  
4/25/2024N/A
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A-$1.60-$1.60N/AN/AN/A
4/25/2024N/A
CNX Resources Co. stock logo
CNX
CNX Resources
$0.36$0.04-$0.32N/A$411.77 million$384.60 million    
2/27/2024Q4 2023
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$0.03-$0.26-$0.29-$0.11$542.07 million$529.50 million    
2/7/2024Q4 2023
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
-$2.15-$1.66+$0.49-$1.66$97.02 million$148.62 million
1/25/202412/31/2023
CNX Resources Co. stock logo
CNX
CNX Resources
$0.30$2.89+$2.59-$1.53$401.62 million$999.50 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Aaron's Company, Inc. stock logo
AAN
Aaron's
$0.506.85%+44.71%625.00%13 Years
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/AN/AN/AN/AN/A
CLZ
Canasil Resources
N/AN/AN/AN/AN/A
CNX Resources Co. stock logo
CNX
CNX Resources
N/AN/AN/AN/AN/A
NVV
Norvista Capital
N/AN/AN/AN/AN/A

Latest AAN, CNX, ASND, NVV, and CLZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/26/2024
The Aaron's Company, Inc. stock logo
AAN
Aaron's
Quarterly$0.12505.87%3/13/20243/14/20244/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Aaron's Company, Inc. stock logo
AAN
Aaron's
0.28
1.04
0.73
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
3.56
2.50
CLZ
Canasil Resources
1.45
0.05
0.14
CNX Resources Co. stock logo
CNX
CNX Resources
0.43
0.51
0.49
NVV
Norvista Capital
0.07
11.62
11.58

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Aaron's Company, Inc. stock logo
AAN
Aaron's
91.99%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
N/A
CLZ
Canasil Resources
N/A
CNX Resources Co. stock logo
CNX
CNX Resources
95.16%
NVV
Norvista Capital
N/A

Insider Ownership

CompanyInsider Ownership
The Aaron's Company, Inc. stock logo
AAN
Aaron's
3.50%
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
40.00%
CLZ
Canasil Resources
7.55%
CNX Resources Co. stock logo
CNX
CNX Resources
3.10%
NVV
Norvista Capital
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Aaron's Company, Inc. stock logo
AAN
Aaron's
9,07131.49 million30.38 millionOptionable
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
87958.22 million34.93 millionOptionable
CLZ
Canasil Resources
N/A143.81 millionN/ANot Optionable
CNX Resources Co. stock logo
CNX
CNX Resources
470153.13 million148.39 millionOptionable
NVV
Norvista Capital
N/A70.14 millionN/ANot Optionable

AAN, CNX, ASND, NVV, and CLZ Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aaron

Aaron's

NYSE:AAN
Headquartered in Atlanta, The Aaron's Company, Inc. (NYSE: AAN) is a leading, technology-enabled, omnichannel provider of lease-purchase solutions. Aaron's engages in direct-to-consumer sales and lease ownership of furniture, appliances, consumer electronics and accessories through its approximately 1,300 company-operated and franchised stores in 47 states and Canada, as well as its e-commerce platform, Aarons.com. For more information, visit Aarons.com or investor.aarons.com.
Ascendis Pharma A/S logo

Ascendis Pharma A/S

NASDAQ:ASND
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Canasil Resources

CVE:CLZ
Canasil Resources Inc. engages in the exploration and development of mineral properties. The company explores for silver, gold, copper, zinc, and lead deposits. It holds 100% interests in the Salamandra zinc-silver project, the La Esperanza silver-gold-zinc-lead project, the Carina silver project, the Colibri silver-zinc-lead-copper project, the Vizcaino silver-gold project, and the Nora silver-gold-copper project located in Durango and Zacatecas States, Mexico. The company also has 100% interests in the Brenda gold-copper property, the Vega gold-copper property, the Granite gold property, and the LIL silver property situated in British Columbia, Canada. Canasil Resources Inc. was incorporated in 1984 and is headquartered in Vancouver, Canada.
CNX Resources logo

CNX Resources

NYSE:CNX
CNX Resources Corporation, an independent natural gas and midstream company, engages in the acquisition, exploration, development, and production of natural gas properties in the Appalachian Basin. The company operates in two segments, Shale and Coalbed Methane (CBM). It produces and sells pipeline quality natural gas primarily for gas wholesalers. The company owns rights to extract natural gas from shale properties in Pennsylvania, West Virginia, and Ohio, as well as rights to extract natural gas from other shale and shallow oil and gas formations in Illinois, Indiana, New York, and Virginia. It also owns rights to extract CBM in Virginia, West Virginia, Pennsylvania, Ohio, Illinois, Indiana, and New Mexico. In addition, the company designs, builds, and operates natural gas gathering systems to move gas from the wellhead to interstate pipelines or other local sales points; owns and operates approximately 2,600 miles of natural gas gathering pipelines, as well as various natural gas processing facilities. It also offers turn-key solutions for water sourcing, delivery, and disposal for its natural gas operations and for third parties. The company was formerly known as CONSOL Energy Inc. and changed its name to CNX Resources Corporation in November 2017. CNX Resources Corporation was founded in 1860 and is headquartered in Canonsburg, Pennsylvania.

Norvista Capital

CVE:NVV
Norvista Capital Corporation operates as a resource investment company and merchant bank in the United States and Canada. It invests in a portfolio of companies that are involved in the exploration of base and precious metals, such as copper, zinc, silver, gold, and lead, as well as oil and gas located in Chile, Manitoba, Yukon, Mexico, and Nevada; and oil and gas in Israel, the United States, Brazil, and Canada. The company was founded in 2014 and is headquartered in Toronto, Canada.